Ortho Clinical Diagnostics, Inc Introduces the VITROS(reg) 350 Chemistry System
The VITROS(reg) 350 System will feature a new flat panel, touch sensitive monitor, with adjustable positions for increased operator ergonomics and ease of use. Additional software updates are expected to provide improved throughput and greater levels of productivity. The VITROS(reg) 350 System software will support the VITROS(reg) Chemistry Products dHDL Slides. This no pretreatment direct HDL method is currently under development.
"Studies have shown that VITROS(reg) Chemistry Systems are the easiest to use and most reliable. They lower hands-on labor costs while improving efficiency," said Bill Schreiber, worldwide product director, Ortho-Clinical Diagnostics, Inc. "With the VITROS(reg) 350, customers will continue to experience these same benefits."
About Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, is a leading provider of high-value diagnostic solutions for the global health care community. Committed to developing the most advanced tests for early detection or diagnosis of disease, the company brings products to market that provide timely information and help to facilitate better medical decisions. Ortho-Clinical Diagnostics, Inc., also provides blood screening and typing products that help to ensure the safety of the world's blood supply. In addition, through its VITROS(reg) MicroSlide(reg) and enhanced chemiluminescence technologies, the company has transformed the way that clinical laboratories perform testing. Worldwide, health care professionals rely on Ortho-Clinical Diagnostics, Inc., for innovative diagnostic solutions that promote effective diagnoses and enhance patient care. For more information, visit www.orthoclinical.com.
* Under development
Ortho Clinical Diagnostics, Inc introduce VITROS (REG) 350 Sistem de Chimie - Ortho Clinical Diagnostics, Inc Introduces the VITROS(reg) 350 Chemistry System - articole medicale engleza - startsanatate